Safety and efficacy of cryoablation of soft-tissue tumours: a systematic review
British Journal of Radiology · 01.06.2025 · 98 (1170) · 861-874
DOI: 10.1093/bjr/tqae075 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Radiology, online erschienen am 08.04.2024. Verfasst von Sylvain Bodard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Cryosurgery, Soft Tissue Neoplasms, Endometriosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH, NCI.
Abstract (Originalsprache)
Objectives
To assess the safety and efficacy of percutaneous cryoablation (CA) of soft-tissue tumours [desmoid tumours (DTs), vascular malformations (VMs), and abdominal wall endometriosis (AWE)].
Methods
This systematic review of studies published before January 2024 encompassed a detailed analysis of CA techniques and technical aspects for the treatment of soft-tissue tumours. Data concerning CA efficacy, complication rates, and other relevant metrics were extracted and included for analysis.
Results
The analysis included 27 studies totalling 554 CA procedures. For DT (13 studies, 393 sessions), CA showed an average pain reduction of 79 ± 17% (range: 57-100) and a lesion volume decrease of 71.5 ± 9.8% (range: 44-97). VM (4 studies, 58 sessions) had a 100% technical success rate and an average pain reduction of 72 ± 25% (range: 63-85). The average pain reduction for AWE (6 studies, 103 sessions) was 82 ± 13% (range: 62-100). Overall, the complication rate for CA was low, with minor adverse events (AEs) in about 20% of patients and major events in less than 5% of patients.
Conclusions
Showing substantial efficacy in pain reduction and lesion volume decrease, as well as low incidence of severe AE, CA presents as a highly effective and safe alternative for the treatment of soft-tissue tumours. Advances in knowledge CA is effective and safe in treating soft-tissue tumours, particularly DT, VM, and AWE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA.
- Department of Radiology, Necker Hospital, University of Paris Cité, Paris 75015, France.
- CNRS UMR 7371, INSERM U 1146, Laboratoire d'Imagerie Biomédicale, Sorbonne University, Paris 75006, France.
- Department of Radiology, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux 33076, France.
- Neuroradiology and MRI Unit, Grenoble Alpes University Hospital, Grenoble Cedex 09, France.
ORCID-Profile: Sylvain Bodard, Francois H Cornelis
Förderung
- NCI NIH HHS
- NIH
- NCI
- Cancer Center
Zitieren
APA
Bodard, S., Marcelin, C., Kastler, A., Dimopoulos, P. M., Petre, E. N., Frandon, J., Razakamanantsoa, L., & Cornelis, F. H. (2025). Safety and efficacy of cryoablation of soft-tissue tumours: a systematic review. British Journal of Radiology, 98(1170), 861-874. https://doi.org/10.1093/bjr/tqae075
Vancouver
Bodard S, Marcelin C, Kastler A, Dimopoulos PM, Petre EN, Frandon J, et al. Safety and efficacy of cryoablation of soft-tissue tumours: a systematic review. British Journal of Radiology. 2025;98(1170):861-874. doi:10.1093/bjr/tqae075
BibTeX
@article{Bodard2025,
author = {Bodard, Sylvain and Marcelin, Clement and Kastler, Adrian and Dimopoulos, Platon M and Petre, Elena N and Frandon, Julien and Razakamanantsoa, Leo and Cornelis, Francois H},
title = {Safety and efficacy of cryoablation of soft-tissue tumours: a systematic review},
journal = {British Journal of Radiology},
year = {2025},
volume = {98},
number = {1170},
pages = {861--874},
doi = {10.1093/bjr/tqae075}
}
EUVIMED